Activated Anion Channel in Hippocampal Astrocytes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897 -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Emerging Roles for Multifunctional Ion Channel Auxiliary Subunits in Cancer T ⁎ Alexander S
Cell Calcium 80 (2019) 125–140 Contents lists available at ScienceDirect Cell Calcium journal homepage: www.elsevier.com/locate/ceca Emerging roles for multifunctional ion channel auxiliary subunits in cancer T ⁎ Alexander S. Hawortha,b, William J. Brackenburya,b, a Department of Biology, University of York, Heslington, York, YO10 5DD, UK b York Biomedical Research Institute, University of York, Heslington, York, YO10 5DD, UK ARTICLE INFO ABSTRACT Keywords: Several superfamilies of plasma membrane channels which regulate transmembrane ion flux have also been Auxiliary subunit shown to regulate a multitude of cellular processes, including proliferation and migration. Ion channels are Cancer typically multimeric complexes consisting of conducting subunits and auxiliary, non-conducting subunits. Calcium channel Auxiliary subunits modulate the function of conducting subunits and have putative non-conducting roles, further Chloride channel expanding the repertoire of cellular processes governed by ion channel complexes to processes such as trans- Potassium channel cellular adhesion and gene transcription. Given this expansive influence of ion channels on cellular behaviour it Sodium channel is perhaps no surprise that aberrant ion channel expression is a common occurrence in cancer. This review will − focus on the conducting and non-conducting roles of the auxiliary subunits of various Ca2+,K+,Na+ and Cl channels and the burgeoning evidence linking such auxiliary subunits to cancer. Several subunits are upregu- lated (e.g. Cavβ,Cavγ) and downregulated (e.g. Kvβ) in cancer, while other subunits have been functionally implicated as oncogenes (e.g. Navβ1,Cavα2δ1) and tumour suppressor genes (e.g. CLCA2, KCNE2, BKγ1) based on in vivo studies. The strengthening link between ion channel auxiliary subunits and cancer has exposed these subunits as potential biomarkers and therapeutic targets. -
Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer
UCSF UC San Francisco Previously Published Works Title Expression profiling of ion channel genes predicts clinical outcome in breast cancer Permalink https://escholarship.org/uc/item/1zq9j4nw Journal Molecular Cancer, 12(1) ISSN 1476-4598 Authors Ko, Jae-Hong Ko, Eun A Gu, Wanjun et al. Publication Date 2013-09-22 DOI http://dx.doi.org/10.1186/1476-4598-12-106 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Ko et al. Molecular Cancer 2013, 12:106 http://www.molecular-cancer.com/content/12/1/106 RESEARCH Open Access Expression profiling of ion channel genes predicts clinical outcome in breast cancer Jae-Hong Ko1, Eun A Ko2, Wanjun Gu3, Inja Lim1, Hyoweon Bang1* and Tong Zhou4,5* Abstract Background: Ion channels play a critical role in a wide variety of biological processes, including the development of human cancer. However, the overall impact of ion channels on tumorigenicity in breast cancer remains controversial. Methods: We conduct microarray meta-analysis on 280 ion channel genes. We identify candidate ion channels that are implicated in breast cancer based on gene expression profiling. We test the relationship between the expression of ion channel genes and p53 mutation status, ER status, and histological tumor grade in the discovery cohort. A molecular signature consisting of ion channel genes (IC30) is identified by Spearman’s rank correlation test conducted between tumor grade and gene expression. A risk scoring system is developed based on IC30. We test the prognostic power of IC30 in the discovery and seven validation cohorts by both Cox proportional hazard regression and log-rank test. -
Ion Channels in Brain Metastasis
International Journal of Molecular Sciences Review Ion Channels in Brain Metastasis Lukas Klumpp 1,2, Efe C. Sezgin 1, Franziska Eckert 1 and Stephan M. Huber 1,* 1 Department of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany; [email protected] (L.K.); [email protected] (E.C.S.); [email protected] (F.E.) 2 Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany * Correspondence: [email protected]; Tel.: +49-7071-29-82183 Academic Editor: Dario Marchetti Received: 7 August 2016; Accepted: 6 September 2016; Published: 8 September 2016 Abstract: Breast cancer, lung cancer and melanoma exhibit a high metastatic tropism to the brain. Development of brain metastases severely worsens the prognosis of cancer patients and constrains curative treatment options. Metastasizing to the brain by cancer cells can be dissected in consecutive processes including epithelial–mesenchymal transition, evasion from the primary tumor, intravasation and circulation in the blood, extravasation across the blood–brain barrier, formation of metastatic niches, and colonization in the brain. Ion channels have been demonstrated to be aberrantly expressed in tumor cells where they regulate neoplastic transformation, malignant progression or therapy resistance. Moreover, many ion channel modulators are FDA-approved drugs and in clinical use proposing ion channels as druggable targets for future anti-cancer therapy. The present review article aims to summarize the current knowledge on the function of ion channels in the different processes of brain metastasis. The data suggest that certain channel types involving voltage-gated sodium channels, ATP-release channels, ionotropic neurotransmitter receptors and gap junction-generating connexins interfere with distinct processes of brain metastazation. -
Ion Channels 3 1
r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia. -
CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A
International Journal of Molecular Sciences Article CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A Raquel Centeio †, Jiraporn Ousingsawat †, Rainer Schreiber and Karl Kunzelmann * Physiological Institute, University of Regensburg, University Street 31, D-93053 Regensburg, Germany; [email protected] (R.C.); [email protected] (J.O.); [email protected] (R.S.) * Correspondence: [email protected] † Equal contribution. Abstract: TMEM16A, a Ca2+-activated chloride channel (CaCC), and its regulator, CLCA1, are asso- ciated with inflammatory airway disease and goblet cell metaplasia. CLCA1 is a secreted protein with protease activity that was demonstrated to enhance membrane expression of TMEM16A. Ex- pression of CLCA1 is particularly enhanced in goblet cell metaplasia and is associated with various lung diseases. However, mice lacking expression of CLCA1 showed the same degree of mucous cell metaplasia and airway hyperreactivity as asthmatic wild-type mice. To gain more insight into the role of CLCA1, we applied secreted N-CLCA1, produced in vitro, to mice in vivo using intra- tracheal instillation. We observed no obvious upregulation of TMEM16A membrane expression by CLCA1 and no differences in ATP-induced short circuit currents (Iscs). However, intraluminal mucus accumulation was observed by treatment with N-CLCA1 that was not seen in control animals. The effects of N-CLCA1 were augmented in ovalbumin-sensitized mice. Mucus production induced by N-CLCA1 in polarized BCi-NS1 human airway epithelial cells was dependent on TMEM16A Citation: Centeio, R.; Ousingsawat, J.; Schreiber, R.; Kunzelmann, K. expression. IL-13 upregulated expression of CLCA1 and enhanced mucus production, however, CLCA1 Regulates Airway Mucus without enhancing purinergic activation of Isc. -
Supplementary Figure S1
Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure S3 Supplementary Figure S4 Supplementary Figure S5 Supplementary Figure S6 Supplementary Table 1: Baseline demographics from included patients Bulk transcriptomics Single cell transcriptomics Organoids IBD non-IBD controls IBD non-IBD controls IBD non-IBD controls (n = 351) (n = 51) (n = 6 ) (n= 5) (n = 8) (n =8) Disease - Crohn’s disease 193 (55.0) N.A. 6 (100.0) N.A. 0 (0.0) N.A. - Ulcerative colitis 158 (45.0) 0 (0.0) 8 (100.0) Women, n (%) 183 (52.1) 34 (66.7) 5 (83.3) 1 (20.0) 4 (50.0) 5 (62.5) Age, years, median [IQR] 41.8 (26.7 – 53.0) 57.0 (41.0 – 63.0) 42.7 (38.5 – 49.5) 71.0 (52.5 – 73.0) 41.3 (35.9 – 46.5) 45.0 (30.5 – 55.9) Disease duration, years, median [IQR] 7.9 (2.0 – 16.8) N.A. 13.4 (5.8 – 22.1) N.A 10.5 (7.8 – 12.7) N.A. Disease location, n (%) - Ileal (L1) 41 (21.3) 3 (50.0) - Colonic (L2) 23 (11.9) N.A. 0 (0.0) N.A. N.A. N.A. - Ileocolonic (L3) 129 (66.8) 3 (50.0) - Upper GI modifier (+L4) 57 (29.5) 0 (0.0) - Proctitis (E1) 13 (8.2) 1 (12.5) - Left-sided colitis (E2) 85 (53.8) N.A. N.A. N.A. 1 (12.5) N.A. - Extensive colitis (E3) 60 (38.0) 6 (75.0) Disease behaviour, n (%) - Inflammatory (B1) 95 (49.2) 0 (0.0) - Fibrostenotic (B2) 55 (28.5) N.A. -
CLCA2 Suppresses the Proliferation, Migration and Invasion of Cervical Cancer
EXPERIMENTAL AND THERAPEUTIC MEDICINE 22: 776, 2021 CLCA2 suppresses the proliferation, migration and invasion of cervical cancer PEIJIN ZHANG1, YANG LIN1 and YAQIONG LIU2 1Department of Gynecology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin 300100; 2Department of Gynecology and Obstetrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China Received April 7, 2020; Accepted January 28, 2021 DOI: 10.3892/etm.2021.10208 Abstract. Ca2+‑activated Cl‑ channel A2 (CLCA2), a tumor Introduction suppressor, is associated with the development of several cancers. However, little is known about CLCA2 in human Cervical carcinoma (CaCx) is one of the most common cervical cancer. Therefore, the aim of the present study was to cancers and one of the leading causes of cancer death among investigate the effects of CLCA2 on cervical cancer. Reverse females, worldwide (1). Despite the recent advances in the transcription‑quantitative (RT‑q)PCR was used to examine the understanding and treatment of this distressing disease, the mRNA expression levels of CLCA2 in eight pairs of cervical prognosis of patients with CaCx remains unsatisfactory due to cancer tissues. Immunohistochemistry was used to investigate the advanced stage of the disease at diagnosis (2). Thus, there CLCA2 protein expression in 144 archived cervical cancer is an urgent need for the identification of biological factors specimens. The association of the CLCA2 with clinicopatho‑ in the tumorigenesis and development of CaCx in order to logical parameters was statistically evaluated. Cell proliferation improve prognosis of advanced CaCx. and invasion capability were examined by MTT and Transwell The Ca2+‑activated Cl‑ channel A2 (CLCA2) is a member assays, respectively. -
Proteomic Identification of Mediators Implicated in the Metastatic Progression of Ovarian Cancer
Proteomic Identification of Mediators Implicated in the Metastatic Progression of Ovarian Cancer by Natasha Musrap A thesis submitted in conformity with the requirements for the degree of Doctorate of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto © Copyright by Natasha Musrap 2015 Proteomic Identification of Mediators Implicated in the Metastatic Progression of Ovarian Cancer Natasha Musrap Doctor of Philosophy Laboratory Medicine and Pathobiology University of Toronto 2015 Abstract Ovarian cancer (OvCa) is the leading cause of death among gynecological malignancies, and is characterized by peritoneal metastasis and increased resistance to chemotherapy. Acquired drug resistance is often attributed to the formation of multicellular aggregates (MCAs) in the peritoneal cavity, which seed abdominal surfaces, particularly, the mesothelial lining of the peritoneum. Given that the presence of metastatic implants is a predictor of poor survival, a better understanding of the underlying biology surrounding OvCa metastasis may lead to the identification of key molecules that are integral to the progression of the disease, which therefore, may serve as practicable therapeutic targets. To that end, in vitro cell line models of cancer-peritoneal interaction and aggregate formation were used to identify proteins that are differentially expressed during cancer progression, using mass spectrometry-based approaches. First, we performed a proteomics analysis of a co-culture model of ovarian cancer and mesothelial cells, in which we identified numerous proteins that were differentially regulated during cancer-peritoneal interaction. We further validated one protein, MUC5AC, and confirmed its expression at the cancer-peritoneal interface. Next, we conducted a quantitative proteomics analysis of a cell line grown as a monolayer and as MCAs. -
Original Article ITGA8 Accelerates Migration and Invasion of Myeloma Cells in Multiple Myelomas
Int J Clin Exp Med 2021;14(2):1126-1132 www.ijcem.com /ISSN:1940-5901/IJCEM0122176 Original Article ITGA8 accelerates migration and invasion of myeloma cells in multiple myelomas Mengmeng Cui1, Jiangfang Feng1, Xuezhong Gu2, Zhuowei Zhang3, Junxia Zhao1, Hongmei Chai1, Jing Li4, Zheng Xu5 1Department of Hematology, Jincheng General Hospital, Jincheng, Shanxi Province, China; 2Department of He- matology, The First People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China; 3Personnel Depart- ment of Shanxi Medical University, Taiyuan, Shanxi Province, China; 4Department of Oncology, Jincheng General Hospital, Jincheng, Shanxi Province, China; 5Department of Orthopaedics, Jincheng General Hospital, Jincheng, Shanxi Province, China Received September 11, 2020; Accepted October 14, 2020; Epub February 15, 2021; Published February 28, 2021 Abstract: Multiple myeloma is cancer of the plasma cells and is the second most common cancer of the blood system, which is characterized by increased calcium levels, renal insufficiency, anemia, bone disease, and suscep- tibility to infection due to suppression of immunoglobulin production. Early diagnosis of multiple myeloma is difficult as it has no symptoms until it reaches an advanced stage. Therefore, key genes involved in the pathogenesis of multiple myeloma might be significant markers for early diagnosis and treatment of the disease. We analyzed the differentially expressed genes in patients with multiple myeloma using sequencing microarrays from the GEO da- tabase. Combined with GO and KEGG analysis, we identified ITGA8 as a key target in the pathogenesis of multiple myeloma, and further verified the differential expression of ITGA8 in myeloma cell lines by rtPCR experiments. Our study contributes to a better understanding of the development of multiple myeloma and advances the application of bioinformatics in clinical diagnosis. -
The Loss of IL-31 Signaling Attenuates Bleomycin-Induced Pulmonary Fibrosis
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.18.423450; this version posted December 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The loss of IL-31 signaling attenuates bleomycin-induced pulmonary fibrosis 1 Dan JK Yombo1,2, Nishanth Gupta3, Anil G. Jegga2,4, and Satish K Madala1,2 2 1Division of Pulmonary Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, 3 Ohio USA. 4 2Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, Ohio 5 USA. 6 3Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, 7 Cincinnati, Ohio USA. 8 4Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, 9 Cincinnati, Ohio USA 10 11 * Correspondence: Dr. Satish K. Madala, Cincinnati Children’s Hospital Medical Center, 12 Division of Pulmonary Medicine, 3333 Burnet Avenue, MLC 2021, Cincinnati, OH 45229. E- 13 mail: [email protected] 14 15 Keywords: Interleukin 31, Interleukin 31 receptor alpha, lung, idiopathic pulmonary fibrosis, 16 bleomycin 17 18 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.18.423450; this version posted December 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. IL-31 regulation of pulmonary fibrosis 19 Abstract 20 Idiopathic Pulmonary Fibrosis (IPF) is a severe fibrotic lung disease characterized by 21 excessive collagen deposition and progressive decline in lung function. Multiple Th2 T cell- 22 derived cytokines including IL-4 and IL-13 have been shown to contribute to inflammation and 23 fibrotic remodeling in multiple tissues.